azasetron has been researched along with granisetron in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakamori, M; Setoguchi, M; Takehara, S | 1 |
| Enomoto, H; Furukawa, M; Ikema, Y; Kawai, S; Kohno, H; Matsuda, H; Mochimatsu, I; Tsukuda, M; Yago, T; Zhou, L | 1 |
| Fukuda, T; Haga, K; Inaba, K; Morimoto, Y; Setoguchi, M; Shoji, H | 1 |
| Kobayashi, S; Kumai, T; Nakura, H; Tanaka, M; Tateishi, T; Watanabe, M | 1 |
| Funakoshi, A; Masuda, M; Miyasaka, K | 1 |
| Asano, K; Fukuda, T; Haga, K; Katayama, K | 1 |
| Ozaki, A; Sukamoto, T | 1 |
| Akamatsu, H; Mikawa, K; Nishina, K; Niwa, Y; Shiga, M | 1 |
| Iwase, O; Okuyama, K; Ozeki, T; Yamada, Y; Yoshimoto, K | 1 |
| Ayuhara, H; Okuyama, K; Ozeki, T; Takayanagi, R; Yamada, Y; Yokoyama, H; Yoshimoto, K | 1 |
| Endo, J; Funaguchi, N; Iihara, H; Ito, F; Itoh, Y; Kamiya, F; Minatoguchi, S; Ohno, Y; Yamada, M; Yanase, K | 1 |
| Iwase, O; Nakajima, A; Nakamura, H; Okuyama, K; Takayanagi, R; Yamada, Y; Yokoyama, H; Yoshimoto, K | 1 |
| Hashizume, J; Higuchi, N; Kitahara, T; Kodama, Y; Matsunaga, N; Nakamura, T; Sakamoto, T; Sasaki, H; Sato, K; Yamaguchi, K | 1 |
2 trial(s) available for azasetron and granisetron
| Article | Year |
|---|---|
[A randomized crossover comparison of azasetron and granisetron in the prophylaxis of emesis induced by chemotherapy including cisplatin].
Topics: Aged; Antiemetics; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; Female; Granisetron; Head and Neck Neoplasms; Humans; Male; Middle Aged; Oxazines; Serotonin Antagonists; Vomiting | 1995 |
A randomized controlled non-inferiority study comparing the antiemetic effect between intravenous granisetron and oral azasetron based on estimated 5-HT3 receptor occupancy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Carboplatin; Female; Granisetron; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Oxazines; Receptors, Serotonin, 5-HT3; Serotonin Antagonists | 2012 |
11 other study(ies) available for azasetron and granisetron
| Article | Year |
|---|---|
[High affinity binding of Y-25130 for serotonin 3 receptor].
Topics: Animals; Antiemetics; Binding, Competitive; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cerebral Cortex; Granisetron; In Vitro Techniques; Indazoles; Male; Ondansetron; Oxazines; Rats; Rats, Wistar; Receptors, Serotonin; Synaptic Membranes | 1992 |
The effects of orally administered Y-25130, a selective serotonin3-receptor antagonist, on chemotherapeutic agent-induced emesis.
Topics: Administration, Oral; Animals; Antiemetics; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; Cyclophosphamide; Dogs; Domperidone; Dose-Response Relationship, Drug; Doxorubicin; Female; Ferrets; Granisetron; Male; Metoclopramide; Ondansetron; Oxazines; Serotonin Antagonists; Vomiting | 1993 |
The activity of dihydropyrimidine dehydrogenase from rat liver was not affected by any of five 5-hydroxytryptamine antagonists.
Topics: Animals; Antiemetics; Antimetabolites, Antineoplastic; Biotransformation; Bridged Bicyclo Compounds, Heterocyclic; Cytosol; Dihydrouracil Dehydrogenase (NADP); Fluorouracil; Granisetron; Indoles; Liver; Male; Ondansetron; Oxazines; Oxidoreductases; Quinolizines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Tropisetron | 1996 |
Involvement of 5-hydroxytryptamine (5-HT)3 receptor mechanisms in regulation of basal pancreatic secretion in conscious rats.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Dose-Response Relationship, Drug; Granisetron; Male; Oxazines; Pancreas; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists | 1997 |
High affinity binding of azasetron hydrochloride to 5-hydroxytryptamine3 receptors in the small intestine of rats.
Topics: Animals; Antiemetics; Binding Sites; Bridged Bicyclo Compounds, Heterocyclic; Granisetron; Intestine, Small; Isotope Labeling; Male; Oxazines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Tritium; Vomiting | 1997 |
Improvement of cisplatin-induced emesis and delayed gastric emptying by KB-R6933, a novel 5-HT3 receptor antagonist.
Topics: Animals; Antiemetics; Antineoplastic Agents; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; Dose-Response Relationship, Drug; Ferrets; Gastric Emptying; Granisetron; Male; Ondansetron; Oxazines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Vomiting | 1999 |
Effects of ondansetron, granisetron, ramosetron, and azasetron on human neutrophil functions.
Topics: Antiemetics; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Chemotaxis, Leukocyte; Granisetron; Humans; Neutrophils; Ondansetron; Oxazines | 2002 |
[Clinical evaluation of antiemetic effects of 5-hydroxytryptamine receptor type 3 (5HT3 receptor) antagonists based on changes in eating condition in cancer patients receiving chemotherapy].
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Eating; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Oxazines; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome; Vomiting | 2008 |
Receptor occupancy theory-based analysis of interindividual differences in antiemetic effects of 5-HT3 receptor antagonists.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Drug Administration Schedule; Granisetron; Humans; Indoles; Models, Theoretical; Ondansetron; Oxazines; Serotonin 5-HT3 Receptor Antagonists; Treatment Outcome; Tropisetron; Vomiting | 2009 |
Theoretical evaluation of antiemetic effects of 5-HT3 receptor antagonists for prevention of vomiting induced by cisplatin.
Topics: Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; Constipation; Creatinine; Granisetron; Humans; Hydroxyindoleacetic Acid; Intestine, Small; Isoquinolines; Models, Biological; Nausea; Oxazines; Palonosetron; Quinuclidines; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2015 |
Evaluation of Antiemetic Therapy for Hepatic Transcatheter Arterial Infusion Chemotherapy with Cisplatin.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Aprepitant; Bridged Bicyclo Compounds, Heterocyclic; Catheterization, Peripheral; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Isoquinolines; Liver; Liver Neoplasms; Male; Middle Aged; Morpholines; Nausea; Oxazines; Palonosetron; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2016 |